|
1
|
Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies.
|
J Viral Hepat
|
2006
|
5.10
|
|
2
|
Estimating progression to cirrhosis in chronic hepatitis C virus infection.
|
Hepatology
|
2001
|
2.90
|
|
3
|
Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis C.
|
Clin Infect Dis
|
2009
|
2.68
|
|
4
|
Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study.
|
BMJ
|
1998
|
2.64
|
|
5
|
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm.
|
J Viral Hepat
|
2014
|
2.23
|
|
6
|
Clinical spectrum of HIV/AIDS in the Asia-Pacific region.
|
AIDS
|
1998
|
2.19
|
|
7
|
Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden.
|
J Viral Hepat
|
2009
|
2.18
|
|
8
|
Historical epidemiology of hepatitis C virus (HCV) in selected countries.
|
J Viral Hepat
|
2014
|
1.68
|
|
9
|
Strategies to manage hepatitis C virus (HCV) disease burden.
|
J Viral Hepat
|
2014
|
1.67
|
|
10
|
HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy.
|
HIV Med
|
2003
|
1.52
|
|
11
|
Primary hepatocellular carcinoma in Australia, 1978-1997: increasing incidence and mortality.
|
Med J Aust
|
2000
|
1.50
|
|
12
|
Nosocomial outbreak of tuberculosis in an outpatient HIV treatment room.
|
AIDS
|
1996
|
1.46
|
|
13
|
Detection of HCV RNA in semen.
|
Lancet
|
2000
|
1.41
|
|
14
|
Sexually transmissible diseases surveillance in Australia: towards a coordinated national system.
|
Commun Dis Intell
|
1998
|
1.40
|
|
15
|
HIV and hepatitis C coinfection within the CAESAR study.
|
HIV Med
|
2004
|
1.39
|
|
16
|
Patterns and characteristics of hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian trial in acute hepatitis C.
|
Clin Infect Dis
|
2011
|
1.32
|
|
17
|
Kaposi's sarcoma and protection from AIDS dementia complex.
|
AIDS
|
1998
|
1.30
|
|
18
|
The impact of injecting drug use status on hepatitis C-related referral and treatment.
|
Drug Alcohol Depend
|
2005
|
1.23
|
|
19
|
Early IL-10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users.
|
J Viral Hepat
|
2010
|
1.23
|
|
20
|
High incidence of hepatitis C virus reinfection within a cohort of injecting drug users.
|
J Viral Hepat
|
2007
|
1.23
|
|
21
|
Estimates on HCV disease burden worldwide - filling the gaps.
|
J Viral Hepat
|
2015
|
1.05
|
|
22
|
Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C infection among a cohort of injecting drug users.
|
Epidemiol Infect
|
2006
|
1.04
|
|
23
|
Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents.
|
J Viral Hepat
|
2011
|
1.02
|
|
24
|
Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study.
|
Drug Alcohol Depend
|
2010
|
1.01
|
|
25
|
Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, Australia.
|
J Viral Hepat
|
2010
|
0.92
|
|
26
|
Improved cognitive function as a consequence of hepatitis C virus treatment.
|
HIV Med
|
2007
|
0.91
|
|
27
|
Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007.
|
J Viral Hepat
|
2011
|
0.90
|
|
28
|
Public health challenges in hepatitis C virus infection.
|
J Gastroenterol Hepatol
|
2000
|
0.89
|
|
29
|
Predicting progression to cirrhosis in chronic hepatitis C virus infection.
|
J Viral Hepat
|
2003
|
0.87
|
|
30
|
Spontaneous clearance and the beneficial impact of treatment on clearance during recent hepatitis C virus infection.
|
J Viral Hepat
|
2010
|
0.87
|
|
31
|
Barriers and facilitators for assessment and treatment of hepatitis C virus infection in the opioid substitution treatment setting: insights from the ETHOS study.
|
J Viral Hepat
|
2013
|
0.83
|
|
32
|
HIV-1 infection among female commercial sex workers in rural Thailand.
|
AIDS
|
1997
|
0.83
|
|
33
|
Experience of hepatitis C testing among injecting drug users in Sydney, Australia.
|
AIDS Care
|
2008
|
0.81
|
|
34
|
Lower life expectancy among people with an HCV notification: a population-based linkage study.
|
J Viral Hepat
|
2014
|
0.81
|
|
35
|
Improving survival following AIDS in Australia, 1991-1996. National HIV Surveillance Committee.
|
AIDS
|
2000
|
0.80
|
|
36
|
Modelling and calibration of the hepatitis C epidemic in Australia.
|
Stat Methods Med Res
|
2008
|
0.80
|
|
37
|
HIV and AIDS in aboriginal and Torres Strait Islander Australians: 1992-1998. The National HIV Surveillance Committee.
|
Med J Aust
|
2000
|
0.79
|
|
38
|
CCR5-Δ32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infection.
|
Genes Immun
|
2013
|
0.78
|
|
39
|
Prevalence of hepatitis C virus infection in the United States.
|
N Engl J Med
|
1999
|
0.78
|
|
40
|
Infant feeding practices and attitudes among women with HIV infection in northern Thailand.
|
AIDS Care
|
2002
|
0.76
|
|
41
|
Isoniazid prophylaxis for high-risk patients with anergy and HIV infection.
|
N Engl J Med
|
1997
|
0.75
|
|
42
|
Hospitalization rates associated with hepatitis B and HIV co-infection, age and sex in a population-based cohort of people diagnosed with hepatitis C.
|
Epidemiol Infect
|
2010
|
0.75
|
|
43
|
Bridging the divide: global inequities in access to HIV/AIDS therapy.
|
Med J Aust
|
2002
|
0.75
|